CREDIT SUISSE AG/ - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q4 2022$8
-99.6%
3
-99.3%
0.00%
Q3 2022$2,000
-99.3%
440
-99.3%
0.00%
Q1 2022$302,000
-4.4%
61,043
+35.0%
0.00%
Q4 2021$316,000
-20.2%
45,202
+14.4%
0.00%
Q3 2021$396,000
-25.1%
39,510
+6.0%
0.00%
Q2 2021$529,000
-24.5%
37,277
-12.9%
0.00%
Q1 2021$701,000
-47.8%
42,797
-34.1%
0.00%
-100.0%
Q4 2020$1,344,000
+2257.9%
64,955
+349.9%
0.00%
Q1 2019$57,000
-74.8%
14,437
-57.0%
0.00%
Q2 2018$226,000
-1.7%
33,567
-5.2%
0.00%
Q1 2018$230,000
+42.9%
35,411
-2.4%
0.00%
Q4 2017$161,000
-89.4%
36,300
-85.2%
0.00%
-100.0%
Q3 2017$1,515,000
+937.7%
245,144
+1452.0%
0.00%
Q2 2017$146,000
+18.7%
15,795
+19.1%
0.00%
Q1 2017$123,000
-72.4%
13,262
-75.1%
0.00%
Q4 2016$446,000
+136.0%
53,183
+92.6%
0.00%
Q3 2016$189,000
+119.8%
27,614
+58.2%
0.00%
Q2 2016$86,000
-87.1%
17,451
-44.9%
0.00%
-100.0%
Q2 2015$667,00031,6810.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q1 2022
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,932,607$40,643,00015.56%
Lamond Capital Partners LLC 711,533$14,964,00015.19%
Polaris Venture Management Co. V, L.L.C. 1,230,009$25,867,00011.54%
NOTTINGHAM ADVISORS, INC. 171,985$3,617,0000.60%
Portolan Capital Management 122,518$2,577,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 160,000$3,365,0000.33%
Rotella Capital Management, Inc. 18,461$388,0000.32%
Monashee Investment Management LLC 28,834$606,0000.29%
DRIEHAUS CAPITAL MANAGEMENT LLC 335,498$7,056,0000.24%
BAILARD, INC. 55,000$1,157,0000.18%
View complete list of OCULAR THERAPEUTIX INC shareholders